Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00125-008-0989-9.pdf
Reference65 articles.
1. Congdom N, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057–2060
2. Tong L, Vernon SA, Kiel W, Sung V, Orr GM (2001) Association of macular involvement with proliferative retinopathy in type 2 diabetes. Diabet Med 18:388–394
3. Klein R, Klein BE, Moss SE, Davis MD, Demets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532
4. Cladwell RB, Bartoli M, Behzadian MA et al (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19:442–455
5. Hernández C, Simó R (2007) Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Invest Drugs 16:1209–26
Cited by 181 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of the effect of intravitreal bevacizumab treatment on left heart function using speckle tracking echocardiography;Revista Portuguesa de Cardiologia;2024-08
2. Bibliometric and visualized analysis of DME from 2012 to 2022;Medicine;2024-03-29
3. Identification of PDGFA as a Neutrophil-related Biomarker Linked to the Advancement of Diabetic Retinopathy through Integrated Bioinformatics Analysis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03-19
4. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression;Experimental Eye Research;2024-02
5. Origin of stage I-II retinopathy;Aspirantskiy Vestnik Povolzhiya;2023-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3